We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Differential Test for Flu A and B

By HospiMedica staff writers
Posted on 01 Nov 2000
A rapid in vitro assay for the direct and qualitative detection of influenza A and B viral antigens has the ability to distinguish the viral antigens of influenza A from those of influenza B, allowing for timely and proper treatment.

The assay was developed by Becton, Dickinson and Company (Sparks, MD, USA). More...
The company says it is an important advance in therapeutic decision-making for several reasons. One is that some antiviral therapies are effective only for influenza A, while others may be used to treat both strains. Thus, the assay can help clarify which treatment should be given. Second, antiviral agents must be given within the first 48 hours of illness to be effective. A test that provides results in 15 minutes promotes such treatment.

The test is an enzyme immunoassay membrane test that can be used with a variety of specimens, such as nasopharyngeal wash, nasopharyngeal aspirate, lower nasal swab, or throat swab. Easy-to-read results are determined by visual color development in the ColorPAC wells of the test device. The development of a purple triangle on the membrane in either the A or B well indicates a positive test. The test is called the BD Directigen Flu A+B.

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.